Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.56 - $20.78 $271,200 - $415,600
-20,000 Reduced 57.14%
15,000 $216,000
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $141,800 - $223,100
10,000 Added 40.0%
35,000 $753,000
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $565,500 - $983,000
25,000 New
25,000 $636,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Venator Management LLC Portfolio

Follow Venator Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venator Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venator Management LLC with notifications on news.